Increased levels of SLC27A2 were validated at both the mRNA and protein levels in breast cancer cell lines, and the knockdown of SLC27A2 inhibited cell proliferation and cell cycle in these cells [50]. The gene discussed is SLC27A2; the disease is breast carcinoma.